Medscape | Success Story of BMT for Blood Cancers Medscape The researchers postulate that significant improvements in overall survival during the 12-year study period are related to advances in high-resolution human leukocyte antigen (HLA) typing, improved supportive care, improved patient selection, a clearer ... |
